US Patent 11129826 Bupropion as a modulator of drug activity
Patent 11129826 was granted and assigned to Axsome Therapeutics on September, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11129826 Bupropion as a modulator of drug activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
